BUY Sharda Cropchem — Anand Rathi, 03 Nov 2026

BUYSharda Cropchem

Sharda Cropchem share price target & all analyst calls

byAnand RathiHorizon: NA (inferred 1 year)3 Nov 2026via Moneycontrol Broker Research

Entry₹671.5Inferred

Target₹1,200

Total upside +78.70%

Stop lossNot given

CMP₹685.61d ago

Active+2.10%+75.03%upside left 12 mo left

Follow Anand Rathi for new calls(50% target hit, 240 closed calls)Get alerts Watch SHARDACROP for new buy/sell callsGet alerts See 6 other Long-term calls on SHARDACROP See 541 other Long-term picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

As of 7 Nov, 5:23 pm IST

4 supporting2 neutral1 opposing

Supports the BUY call (4)

Sharda Cropchem reported Q2 FY27 revenue of Rs 1,052 crore, up 13% YoY, and EBITDA of Rs 164 crore, up 18% YoY. The company maintains its FY27 revenue growth guidance of 10-15%.

NSE · Press Release·30 Oct · 1w ago

Sharda Cropchem reported its financial results for the quarter and half-year ended September 30, 2026, showing a 13% YoY increase in total revenue to Rs 1,052 crore for Q2 FY27.

NSE · Press Release·30 Oct · 1w ago

Sharda Cropchem reported Q2 FY27 revenue of Rs 1,052 crore, up 13% YoY, and EBITDA of Rs 164 crore, up 18% YoY. The company remains debt-free with Rs 846 crore in liquid investments.

BSE · Company Update·30 Oct · 1w ago

2 other SEBI-registered advisors have active long-term BUY calls on this stock

Advisor consensus · same horizon·30 Sept · 1mo ago

Neutral / worth noting (2)

Sharda Cropchem reported unaudited standalone and consolidated financial results for the quarter and half-year ended September 30, 2026.

NSE · Outcome of Board Meeting·30 Oct · 1w ago

Weighs against the BUY call (1)

Long-term trend bearish — 200-day average falling over the past quarter

Technicals · trend·6 Nov · yesterday

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

Other calls on Sharda Cropchem

All analyst calls on Sharda Cropchem

More from Anand Rathi

Every call and its outcome